ReviewTaiwan journal of ophthalmology
Role of artificial intelligence in optical coherence tomography in myopia and pathological myopia.
Review in Taiwan journal of ophthalmology. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Myopia and pathological myopia (PM) have been recognized as one of the leading causes of visual impairment globally. Optical coherence tomography (OCT) provides high-resolution imaging of retinal and choroidal structural changes and plays an increasing role in the diagnosis and prognostication of PM and myopia-related complications. Recent advances in OCT technology have produced a potential platform for artificial intelligence (AI), particularly deep learning (DL), to enhance diagnostic accuracy and prognostic capabilities. First, AI-assisted detection of myopia based on OCT-derived biomarkers such as retinal curvature, optic nerve morphology, and inner retinal thinning have the potential to detect high myopia. However, precise refractive error estimation or differentiation of lower-grade myopia remains modest. Future integration of OCT angiography may refine the prediction of myopia progression. Second, AI may improve automated segmentation and quantification of the choroid, with DL algorithms consistently delineating choroidal boundaries and quantifying region-specific choroidal thicknesses. Recent algorithms have extended beyond basic segmentation to choroidal sublayer segmentation and calculating choroidal vascularity indices, enhancing structural characterization in myopic eyes. Third, AI methods have advanced the detection of PM-related OCT lesions, reliably identifying critical lesions including myopic traction maculopathy, myopic choroidal neovascularization, and dome-shaped macula. Recent models have also shown the ability to categorize disease severity according to validated clinical frameworks, such as the Atrophy-Traction-Neovascularization and myopic tractional maculopathy staging systems. Despite these advances, current AI methods face challenges including inconsistent OCT protocols, limited longitudinal data, inadequate external validation, and difficulties handling poor-quality scans. Addressing these limitations could facilitate clinical integration, enhancing early diagnosis, prognostication, and possibly, personalized myopia management in the future.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.